Figure 2.

Effect of the timing of discontinuation of MET inhibitor on survival. Kaplan-Meier curves: (A) estimated median MET amplification ctDNA clearance time; PFS (B) and OS (C) according to the timing of discontinuing MET inhibitor. CI, confidence interval; HR, hazard ratio; PFS, progression-free survival; OS, overall survival; ctDNA, circulating tumor DNA.